Mexico
+918669251513

SORANBI Sorafenib Tablets 200 mg – Targeted Therapy for Liver, Kidney & Thyroid Cancer

update image
Brand: SORANBI Generic Name: Sorafenib Strength: 200 mg Form: Oral Tablets Manufacturer: Cipla Availability: In Stock | Ships Worldwide Exported by: Unnati Pharmax Product Overview SORANBI Sorafenib Tablets 200 mg is an advanced oral targeted therapy prescribed for the treatment of primary liver cancer (hepatocellular carcinoma), advanced kidney cancer (renal cell carcinoma), and certain types of thyroid cancer. It is a globally trusted oncology medication recommended for patients when surgery or other treatments are not suitable. SORANBI works by blocking multiple kinases responsible for tumor growth and angiogenesis (formation of new blood vessels). By interrupting these critical pathways, it slows the spread of cancer, restricts tumor progression, and improves patient outcomes. Why Choose SORANBI Sorafenib 200 mg? βœ… Clinically proven targeted therapy for liver, kidney, and thyroid cancers βœ… Multi-kinase inhibitor that disrupts tumor growth and blood supply βœ… Oral tablet form for easy and convenient administration βœ… Widely used in global oncology treatment plans βœ… Trusted by oncologists worldwide for effective cancer management How It Works Sorafenib in SORANBI acts as a multi-kinase inhibitor targeting RAF kinases, VEGFR, and PDGFR receptors, which are essential for tumor development and blood vessel formation. By blocking these pathways, SORANBI reduces cancer cell growth and cuts off the tumor’s blood supply, helping control disease progression. Composition Each tablet contains: Sorafenib Tosylate equivalent to Sorafenib 200 mg Dosage and Administration Take SORANBI as directed by your oncologist Usual dosage: 400 mg per day (two 200 mg tablets), taken in two divided doses Swallow the tablets whole with water, preferably on an empty stomach or as prescribed Buy SORANBI Sorafenib 200 mg Online Looking for affordable and authentic Sorafenib tablets online? Order SORANBI 200 mg today from Unnati Pharmax, your trusted global exporter of oncology and specialty medicines. We ensure: βœ… 100% genuine, high-quality medicine βœ… Fast and secure worldwide shipping βœ… Discreet packaging for customer confidentiality βœ… Competitive pricing for both bulk and retail orders FAQs – SORANBI Sorafenib 200 mg Q1: What cancers is SORANBI used to treat? A1: SORANBI is indicated for liver cancer (HCC), advanced kidney cancer (RCC), and certain thyroid cancers. Q2: How is SORANBI usually taken? A2: The usual dosage is 200 mg twice daily, or as prescribed by your oncologist. Q3: When can treatment results be expected? A3: Many patients see delayed disease progression within the first few months, though response times may vary.
 2025-08-16T18:30:21

Related Posts

update image

SORABUZZ Sorafenib Tablets 200 mg – Targeted Therapy for Liver, Kidney & Thyroid Cancer

2025-08-16T12:22:27 , update date

 2025-08-16T12:22:27
update image

Sorafenat Sorafenib Tablets 200 mg – Targeted Therapy for Liver, Kidney & Thyroid Cancer

2025-08-16T12:12:12 , update date

 2025-08-16T12:12:12
update image

Sorafikast Sorafenib Tablets 200 mg – Targeted Therapy for Liver, Kidney & Thyroid Cancer

2025-08-16T12:08:05 , update date

 2025-08-16T12:08:05